More claims have been filed in several courts across the United States against the makers of anticoagulant medication Xarelto. The new claims were made in the states of Vermont, New York and Florida. The original claim was made in Pennsylvania
The claims made are that the companies behind the drug did not warn healthcare professionals and patients about the excessive internal bleeding caused by Xarelto in some cases.
The latest allegations include the claim that the companies involved knew there was no antidote for the uncontrolled bleeding but did not adequately publicize that fact.
Here is an excerpt from one of the claims in Florida:
“Defendants’ boxed warning did not address the increased risk for serious and fatal bleeding, despite the fact that the information listed on their website…states that in comparison to warfarin, patients have more gastrointestinal bleeds and need more transfusions…”
Warfarin is an older, widely used blood thinning medication that came out long before Xarelto.
The claims also say that the public was misled, thinking the drug was safe to use. But in reality the medication is linked to internal bleeding in the rectum, intestines and abdomen. It’s also linked to brain hemorrhaging. Some of the latest cases are on behalf of plaintiffs who succumbed to sudden death.
In the complaints the claim is made that within the first three months of 2013 the number of “serious adverse events” from taking Xarelto had overtaken Pradaxa, which formerly held the number 1 spot. The drug was rejected by the FDA before the lawsuits as a treatment for Acute Coronary Syndrome.
Lawyers expect that more people will come forward over time to join the xarelto lawsuits that are already in progress.